Biomarkers: newborn screening for epilepsy in sight -- MEDICA - World Forum for Medicine

Biomarkers: newborn screening for epilepsy in sight

14.07.2021

Image: The heels of a newborn with the marks of two blood pricks; Copyright: PantherMedia/antibydni

Currently, there are over a thousand known inborn metabolic diseases (IMD), but only 2% of them can be detected through the neonatal heel prick. While these are relatively rare as individual disorders, in the Netherlands, every other day a child is born with an IMD.

More topic-related exciting news from the editors of MEDICA-tradefair.com